Praxis Precision Medicines (PRAX) Misses Q1 EPS by 42c

Praxis Precision Medicines (NASDAQ: PRAX) reported Q1 EPS of ($3.29), $0.42 worse than the analyst estimate of ($2.87).

For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• UBS Upgrades E.ON SE (EOAN:GR) (EONGY) to Buy
• RBC Capital Reiterates Outperform Rating on Aviva PLC (AV:LN) (AVVIY)